A Study to Evaluate the Effect of the Combination of Umeclidinium (UMEC) and Vilanterol (VI) on Exercise Endurance Time (EET) in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Condition: Pulmonary Disease, Chronic ObstructiveInterventions: Drug: UMEC/VI DPI; Drug: Placebo DPI; Drug: Albuterol/salbutamol MDISponsor: GlaxoSmithKlineRecruiting - verified February 2015

http://clinicaltrials.gov/ct2/show/NCT02275052?lup_s=02%2F17%2F2015&lup_d=30

Source: ClinicalTrials.gov - October 23, 2014 Category: Research Source Type: clinical trials